Jesy Nelson has questioned Health Secretary Wes Streeting about the delay in addressing her situation with a severe muscle wasting disease before it became a pressing issue. The former member of the popular group Little Mix met with Mr. Streeting to advocate for the inclusion of newborn screening for spinal muscular atrophy (SMA), a condition her twin babies have been diagnosed with, which is expected to hinder their ability to walk.
The Mirror has been campaigning for the addition of a simple £5 SMA check to the NHS newborn heel prick test, enabling early detection and treatment to prevent irreversible nerve damage in infants, aligning with practices in many other developed countries.
During a recorded meeting featured on ITV’s This Morning, Jesy expressed her frustration at the necessity for her intervention to draw attention to the issue. Mr. Streeting acknowledged the significance of her efforts, acknowledging the numerous families in similar situations who appreciate her advocacy.
Jesy emphasized the urgency of implementing SMA screening in the newborn test, highlighting the availability of life-changing treatments that could alter the outcomes for affected children significantly. The charity SMA UK also emphasized the critical repercussions of delayed diagnoses during the meeting with Mr. Streeting, underscoring the need for swift action to prevent unnecessary suffering.
Despite the National Screening Committee’s previous decision against including SMA in the newborn screening program, recent advancements in SMA treatments have prompted a reevaluation. While a pilot program is being prepared to assess the impact of screening in select regions of England, Scotland has already committed to integrating SMA screening into routine newborn testing starting this spring.
Novartis, a pharmaceutical company, estimated that 33 UK infants annually face mobility challenges due to delayed SMA diagnoses. The availability of innovative gene therapies for SMA reinforces the importance of early detection and intervention to improve outcomes for affected children.
Efforts are ongoing to expedite the evaluation process for expanding SMA screening nationwide, with a focus on enhancing the screening program to benefit all infants. The collaborative efforts of advocates like Jesy and organizations like SMA UK are vital in driving progress and ensuring a brighter future for children affected by SMA.
